{"id":"parentral-iron","safety":{"commonSideEffects":[{"rate":"5–15","effect":"Injection site pain or phlebitis"},{"rate":"3–10","effect":"Headache"},{"rate":"2–8","effect":"Nausea"},{"rate":"0.5–2","effect":"Hypersensitivity reactions (including anaphylaxis with iron dextran)"},{"rate":"2–5","effect":"Abdominal pain"},{"rate":"2–5","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL1200823","moleculeType":"Small molecule","molecularWeight":"398.14"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Parenteral iron formulations (such as iron dextran, iron sucrose, or ferric carboxymaltose) are administered intravenously or intramuscularly to rapidly restore iron levels in patients with iron deficiency anemia who cannot tolerate or absorb oral iron supplements. The iron is transported to bone marrow and incorporated into hemoglobin and myoglobin, restoring oxygen-carrying capacity and correcting anemia.","oneSentence":"Parenteral iron replenishes depleted iron stores by delivering iron directly into the bloodstream or muscle tissue, bypassing gastrointestinal absorption limitations.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:59:48.872Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients intolerant to or unable to absorb oral iron"},{"name":"Iron deficiency anemia in chronic kidney disease patients"},{"name":"Perioperative iron supplementation"}]},"trialDetails":[{"nctId":"NCT04228627","phase":"PHASE4","title":"Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial","status":"COMPLETED","sponsor":"Services Institute of Medical Sciences, Pakistan","startDate":"2020-01-14","conditions":"Iron Deficiency (Without Anemia), Pregnancy Related","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Parentral Iron","genericName":"Parentral Iron","companyName":"Services Institute of Medical Sciences, Pakistan","companyId":"services-institute-of-medical-sciences-pakistan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Parenteral iron replenishes depleted iron stores by delivering iron directly into the bloodstream or muscle tissue, bypassing gastrointestinal absorption limitations. Used for Iron deficiency anemia in patients intolerant to or unable to absorb oral iron, Iron deficiency anemia in chronic kidney disease patients, Perioperative iron supplementation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}